Results 81 to 90 of about 84,996 (200)
Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group [PDF]
\01-RSV-Mat-Ped-Long-508 ...
core +8 more sources
ACIP Adult RSV Work Group Considerations : Respiratory Syncytial Virus (RSV) in Adults ; Use of RSV vaccines in adults aged 50\u201359 years [PDF]
04-Britton-Adult-RSV-508 ...
core
Nabil S Dhayhi,1,* Ali Aqeel,2,* Salman Ghazwani,3 Ibrahim M Gosadi,4 Haleemah Mohammed AlQassimi,5 Abdullah Thubab,6 Ibrahim Abdullah Sairam,6 Majed Ahmed Hakami,6 Fahd Ahmed Sawan,6 Sabreen Mohammed Asiry,7 Mawahib Khalifa,7 Hadi Daghreeri,8 ...
Dhayhi NS +17 more
doaj
Increase in febrile illness among children in mainland China, winter 2023 - 2024
In late 2023, mainland China reportedly saw a rise in respiratory illnesses, primarily among children. Officials from the Chinese Center for Disease Control attributed this increase to the circulation of known pathogens, including influenza viruses ...
Joel Keep, David Heslop
doaj +1 more source
Effectiveness of RSV Vaccines against RSV-Associated Thromboembolic Events
We evaluated effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated thromboembolic events among community-dwelling Medicare fee-for-service beneficiaries >65 years of age in the United States enrolled during October 1, 2023-March 30, 2024. RSV vaccines protected against RSV-associated thromboembolic events (effectiveness 79%
Wiegand, Ryan E. +12 more
openaire +3 more sources
: Background The majority of respiratory syncytial virus (RSV) infections in young children are managed in primary care, however, the disease burden in this setting remains poorly defined.
Raes, Marc +16 more
core
Production of lung eosinophilia in the mouse model of respiratory syncytial virus (RSV)
Copyright information:Taken from "Potential therapeutic implications of new insights into respiratory syncytial virus disease"http://respiratory-research.com/content/3/S1/S15Respiratory Research 2002;3(Suppl 1):S15-S20.Published online 24 Jun 2002PMCID ...
Peter JM Openshaw (73522)
core +1 more source
RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine
International audienceRespiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in children, yet no vaccine is available. The sole licensed preventive treatment against RSV is composed of a monoclonal neutralizing antibody ...
Riffault, Sabine +7 more
core +1 more source

